255 related articles for article (PubMed ID: 37394559)
21. Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T.
Aryal MP; Nagaraja TN; Keenan KA; Bagher-Ebadian H; Panda S; Brown SL; Cabral G; Fenstermacher JD; Ewing JR
Magn Reson Med; 2014 Jun; 71(6):2206-14. PubMed ID: 23878070
[TBL] [Abstract][Full Text] [Related]
22. Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.
Feng S; Yin J
Front Oncol; 2022; 12():847880. PubMed ID: 36895526
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Yu X; Song W; Guo D; Liu H; Zhang H; He X; Song J; Zhou J; Liu X
Front Oncol; 2020; 10():459. PubMed ID: 32328461
[No Abstract] [Full Text] [Related]
24. DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.
Dehkordi ANV; Kamali-Asl A; Wen N; Mikkelsen T; Chetty IJ; Bagher-Ebadian H
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28543885
[TBL] [Abstract][Full Text] [Related]
25. Tissue response curve-shape analysis of dynamic glucose-enhanced and dynamic contrast-enhanced magnetic resonance imaging in patients with brain tumor.
Seidemo A; Wirestam R; Helms G; Markenroth Bloch K; Xu X; Bengzon J; Sundgren PC; van Zijl PCM; Knutsson L
NMR Biomed; 2023 Jun; 36(6):e4863. PubMed ID: 36310022
[TBL] [Abstract][Full Text] [Related]
26. A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas.
Wang J; Hu Y; Zhou X; Bao S; Chen Y; Ge M; Jia Z
Eur J Radiol; 2022 Feb; 147():110141. PubMed ID: 34995947
[TBL] [Abstract][Full Text] [Related]
27. Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection.
Chwang WB; Jain R; Bagher-Ebadian H; Nejad-Davarani SP; Iskander AS; VanSlooten A; Schultz L; Arbab AS; Ewing JR
J Magn Reson Imaging; 2014 Nov; 40(5):1223-9. PubMed ID: 24421265
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
[TBL] [Abstract][Full Text] [Related]
29. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
Haeck J; Bol K; Bison S; van Tiel S; Koelewijn S; de Jong M; Veenland J; Bernsen M
Contrast Media Mol Imaging; 2015; 10(6):413-20. PubMed ID: 25995102
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
32. Radiomic Analysis of Multi-parametric MR Images (MRI) for Classification of Parotid Tumors.
Fathi Kazerooni A; Nabil M; Alviri M; Koopaei S; Salahshour F; Assili S; Saligheh Rad H; Aghaghazvini L
J Biomed Phys Eng; 2022 Dec; 12(6):599-610. PubMed ID: 36569565
[TBL] [Abstract][Full Text] [Related]
33. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
34. A hybrid hemodynamic knowledge-powered and feature reconstruction-guided scheme for breast cancer segmentation based on DCE-MRI.
Lv T; Wu Y; Wang Y; Liu Y; Li L; Deng C; Pan X
Med Image Anal; 2022 Nov; 82():102572. PubMed ID: 36055051
[TBL] [Abstract][Full Text] [Related]
35. Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer.
Coolens C; Driscoll B; Foltz W; Svistoun I; Sinno N; Chung C
Br J Radiol; 2019 Apr; 92(1096):20170461. PubMed ID: 30235004
[TBL] [Abstract][Full Text] [Related]
36. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
37. Toward a noninvasive estimate of interstitial fluid pressure by dynamic contrast-enhanced MRI in a rat model of cerebral tumor.
Elmghirbi R; Nagaraja TN; Brown SL; Keenan KA; Panda S; Cabral G; Bagher-Ebadian H; Divine GW; Lee IY; Ewing JR
Magn Reson Med; 2018 Nov; 80(5):2040-2052. PubMed ID: 29524243
[TBL] [Abstract][Full Text] [Related]
38. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
39. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
[TBL] [Abstract][Full Text] [Related]
40. Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Guo L; Du S; Gao S; Zhao R; Huang G; Jin F; Teng Y; Zhang L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
